World Post Menopausal Vaginal Atrophy Drugs Market Drivers and Challenges Report 2020

Submitted by: Submitted by

Views: 10

Words: 575

Pages: 3

Category: Business and Industry

Date Submitted: 05/09/2016 06:37 AM

Report This Essay

Global Post Menopausal Vaginal Atrophy Drugs Market 2016-2020 is new market research report on RnRMarketResearch.com including 69 Pages and provides 48 Exhibits.

The analysts forecast global PVA drugs market to grow at a CAGR of 7.13% during the period 2016-2020. Vaginal atrophy also known as atrophic vaginitis is defined as a decrease in the production of estrogen after menopause, leading to thinning, drying, and reduced elasticity of the vaginal tissues. Up to 40% of post-menopausal women have symptoms of atrophic vaginitis. It typically affects women in the age group of 45-55 years. PVA result in symptoms such as itching, burning, dryness, and dyspareunia. Topical preparations such as hormone replacement therapy (HRT) and estrogen creams are used to treat PVA.

Complete report available @ http://www.rnrmarketresearch.com/global-post-menopausal-vaginal-atrophy-drugs-market-2016-2020-market-report.html?utm_source=Fpro&utm_medium=Promotion&utm_campaign=SEO

This report covers the present scenario and the growth prospects of the global PVA drugs market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of drugs (creams, tablets, patches, and rings) used to treat PVA.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Purchase a Copy of the Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=534735&utm_source=Fpro&utm_medium=Promotion&utm_campaign=SEO (Single User License - US $2500)

The report, Global Post-Menopausal Vaginal Atrophy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors : Pfizer Inc., Allergan Inc., Shionogi & Co. Ltd., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd.

Other prominent vendors :...